Proteins by Design® XmAb® Antibody & Cytokine Therapeutics ® Corporate Overview November 2022 Forward-Looking Statements Certain statements contained in this presentation, other than statements of historical fact, may constitute forwardlooking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding Xencor's development plans and timelines; potential regulatory actions; expected use of cash resources; the tim ...